Literature DB >> 9317015

Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei.

K Miyagi1, K Kawakami, A Saito.   

Abstract

We examined the contributions of reactive nitrogen and oxygen intermediates (RNI and ROI, respectively) in macrophage bactericidal activity against Burkholderia pseudomallei, the causative agent of melioidosis, in order to understand host defense mechanisms against infection caused by this bacterium. The bacteria multiplied in unstimulated murine macrophage cell line J774.1. However, a strong dose-dependent inhibition of intracellular bacterial growth was observed when gamma interferon (IFN-gamma)-activated macrophages were used. The induction of bactericidal activity correlated well with the production of nitric oxide (NO) by IFN-gamma-activated macrophages and was markedly suppressed by N(G)-monomethyl L-arginine (L-NMMA), a competitive inhibitor of NO synthesis. Superoxide dismutase (SOD) and catalase significantly inhibited macrophage bactericidal activity, and the combined addition of L-NMMA, SOD, and catalase resulted in the complete inhibition of IFN-gamma-stimulated activity. The bacteria were susceptible to the killing effects of chemically generated NO and superoxide anion in a macrophage-free system. Our results indicate that IFN-gamma-induced macrophage bactericidal activity against B. pseudomallei is mediated to a large extent by RNI killing mechanisms and to a lesser extent by ROI-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317015      PMCID: PMC175591          DOI: 10.1128/iai.65.10.4108-4113.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.

Authors:  J A Langermans; M E Van der Hulst; P H Nibbering; P S Hiemstra; L Fransen; R Van Furth
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

2.  Catecholamines and virulence of Cryptococcus neoformans.

Authors:  I Polacheck; Y Platt; J Aronovitch
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.

Authors:  R Radi; J S Beckman; K M Bush; B A Freeman
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

4.  L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae.

Authors:  L B Adams; S G Franzblau; Z Vavrin; J B Hibbs; J L Krahenbuhl
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

5.  Relapse in melioidosis: incidence and risk factors.

Authors:  W Chaowagul; Y Suputtamongkol; D A Dance; A Rajchanuvong; J Pattara-arechachai; N J White
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

6.  Inhibition of nitric oxide synthase by a superoxide generating system.

Authors:  A Rengasamy; R A Johns
Journal:  J Pharmacol Exp Ther       Date:  1993-12       Impact factor: 4.030

7.  Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase.

Authors:  R M Clancy; J Leszczynska-Piziak; S B Abramson
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.

Authors:  R T Gazzinelli; I P Oswald; S Hieny; S L James; A Sher
Journal:  Eur J Immunol       Date:  1992-10       Impact factor: 5.532

9.  Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide.

Authors:  N Hogg; V M Darley-Usmar; M T Wilson; S Moncada
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

10.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.

Authors:  J Chan; Y Xing; R S Magliozzo; B R Bloom
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  46 in total

1.  Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection.

Authors:  Katie L Propst; Ryan M Troyer; Lisa M Kellihan; Herbert P Schweizer; Steven W Dow
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

Review 2.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

3.  Cationic liposomes extend the immunostimulatory effect of CpG oligodeoxynucleotide against Burkholderia pseudomallei infection in BALB/c mice.

Authors:  Apichaya Puangpetch; Robert Anderson; Yan Y Huang; Rasana W Sermswan; Wanpen Chaicumpa; Stitaya Sirisinha; Surasakdi Wongratanacheewin
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

4.  Protection from pneumonic infection with burkholderia species by inhalational immunotherapy.

Authors:  Andrew Goodyear; Lisa Kellihan; Helle Bielefeldt-Ohmann; Ryan Troyer; Katie Propst; Steven Dow
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

5.  Murine macrophages use oxygen- and nitric oxide-dependent mechanisms to synthesize S-nitroso-albumin and to kill extracellular trypanosomes.

Authors:  A P Gobert; S Semballa; S Daulouede; S Lesthelle; M Taxile; B Veyret; P Vincendeau
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei-infected mouse macrophages.

Authors:  P Utaisincharoen; N Anuntagool; S Arjcharoen; K Limposuwan; P Chaisuriya; S Sirisinha
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects.

Authors:  Sujin Chanchamroen; Chidchamai Kewcharoenwong; Wattanachai Susaengrat; Manabu Ato; Ganjana Lertmemongkolchai
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

8.  Identification of a novel two-partner secretion system from Burkholderia pseudomallei.

Authors:  N F Brown; C-A Logue; J A Boddey; R Scott; R G Hirst; I R Beacham
Journal:  Mol Genet Genomics       Date:  2004-08-13       Impact factor: 3.291

9.  Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.

Authors:  Surasakdi Wongratanacheewin; Wannapa Kespichayawattana; Pakamas Intachote; Sathit Pichyangkul; Rasana W Sermswan; Arthur M Krieg; Stitaya Sirisinha
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Innate immune responses of pulmonary epithelial cells to Burkholderia pseudomallei infection.

Authors:  Siew Hoon Sim; Yichun Liu; Dongling Wang; Vidhya Novem; Suppiah Paramalingam Sivalingam; Tuck Weng Thong; Eng Eong Ooi; Gladys Tan
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.